Magdalena Schwarzmuller

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B.

Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B.

Journal: medRxiv : the preprint server for health sciences

Published: July 17, 2026

ART-DEX: A novel strategy to monitor broadly neutralizing antibody activity during antiretroviral therapy of HIV-1.

ART-DEX: A novel strategy to monitor broadly neutralizing antibody activity during antiretroviral therapy of HIV-1.

Journal: STAR protocols

Published: February 27, 2024

Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines.

Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines.

Journal: Cell reports. Medicine

Published: February 26, 2024

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.

Journal: mBio

Published: January 25, 2024

Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study.

Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study.

Journal: The Journal of infectious diseases

Published: July 20, 2023

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.

Journal: RMD open

Published: July 13, 2022

Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response.

Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response.

Journal: The Journal of clinical investigation

Published: January 06, 2022

Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.

Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.

Journal: BMJ open

Published: July 27, 2021

Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity.

Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity.

Journal: Nature communications

Published: April 14, 2021

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.

Journal: BMJ (Clinical research ed.)

Published: March 18, 2021

HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11.

HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11.

Journal: PLoS pathogens

Published: February 05, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026